Linus Pauling Institute

Pearce MC, Satterthwait AC, Zhang X-K, Kolluri SKumar.  2019.  Cancer therapeutics based on BCL-2 functional conversion.. Apoptosis. 24(1-2):1-2.

Song Z, Pearce MC, Jiang Y, Yang L, Goodall C, Miranda CL, Milovancev M, Bracha S, Kolluri SK, Maier CS.  2020.  Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.. Sci Rep. 10(1):727.

Song Z, Pearce MC, Jiang Y, Yang L, Goodall C, Miranda CL, Milovancev M, Bracha S, Kolluri SK, Maier CS.  2020.  Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.. Sci Rep. 10(1):727.

Morgan E, Gamble JT, Pearce MC, Elson DJ, Tanguay RL, Kolluri SKumar, Reich NO.  2019.  Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.. Apoptosis.

Pearce MC, Gamble JT, Kopparapu PR, O'Donnell EF, Mueller MJ, Jang HSang, Greenwood JA, Satterthwait AC, Tanguay RL, Zhang X-K et al..  2018.  Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.. Oncotarget. 9(40):26072-26085.